JE Cleantech – Singapore-based Precision Cleaning Leader Sees Growth in Revenue and Net Income in H1 2023
SINGAPORE, Oct 3, 2023 – (ACN Newswire) – JE Cleantech Holdings Limited (“JE Cleantech” or…
News
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101
SAN FRANCISCO, CA and TAIPEI, TAIWAN, Oct 3, 2023 – (ACN Newswire) – HanchorBio Inc.,…
The World’s First AI-Created Digital Children’s Spokesperson ‘Uni’ is Ready to Amplify the Voices of Children Around the World
BILLUND, DENMARK, Oct 3, 2023 – (ACN Newswire) – A manifesto and 40 ideas addressing…
OSI Systems Awarded 10-Year Contract for Cargo Turnkey Screening in Uruguay
HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that…
Akkio Launches Generative Reports to Turn Data Into Decisions Instantly
First-of-its-Kind Generative Business Intelligence Feature Empowers Small and Medium Businesses with Automatic, AI-powered Insights CAMBRIDGE,…
OpenX Teams up with Cedara to Become the First Adtech Platform to Deliver a Complete Programmatic Campaign Emissions Solution
The partnership provides buyers a sustainable supply path through fully integrated carbon emissions measurement, reduction…
Conversica Recognized in Salesforce 2023 Partner Innovation Awards
Conversica Demonstrates Excellence within Salesforce Ecosystem SAN MATEO, Calif.–(BUSINESS WIRE)–#AI—Conversica, Inc. announced that it has…
ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
— Evorpacept is the first CD47 blocker to show activity in a global randomized study in…
Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar…
Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland and PISCATAWAY, N.J., Oct. 03, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a…
TD SYNNEX Report: AI Offerings Grow 625% Globally in One Year among Technology Resellers
2023 Direction of Technology Report Reveals Critical Role of High-Growth Technologies and Ecosystem Partnership to…
FendX Successfully Completes Pilot Run to Manufacture REPELWRAP(TM) Film using Dunmore’s Commercial Equipment
Over 5,000 feet of REPELWRAP™ film was produced using Dunmore’s commercial manufacturing line. Film production…
MHI Completes Acquisition of Concentric, LLC
TOKYO, Oct 3, 2023 – (JCN Newswire) – TOKYO, Oct 3, 2023 – (JCN Newswire)…
WARC releases The Future of Strategy 2023, a worldwide survey-led report with insights from almost 1,000 marketing strategists
LONDON, Oct 3, 2023 – (ACN Newswire) – As tough economic conditions continue to squeeze…
Botify Announces New Measurement Benchmark Model for Confidently Calculating Return on Organic Search Spend
Early-stage client testing and input validates a new measurement standard for reliably calculating the return…
Global Energy and Chemical Leaders Partner to Develop a Large-Scale, Low-Carbon Ammonia Production Export Project on the Houston Ship Channel
TOKYO & PARIS & OKLAHOMA CITY & HOUSTON–(BUSINESS WIRE)–Tokyo-based INPEX Corporation (TSE: 1605) (“INPEX”), Paris-based…
Botify Announces New Measurement Benchmark Model for Confidently Calculating Return on Organic Search Spend
Early-stage client testing and input validates a new measurement standard for reliably calculating the return…
Spendesk Adopts Platformatic to Enhance Backend Development Efficiency
SAN FRANCISCO–(BUSINESS WIRE)–Platformatic, the modern backend development platform, is pleased to announce that Spendesk, a…
Faron to Host Webcast to Discuss New Data From Phase I/II BEXMAB Study of Bexmarilimab and Provide Update on the Development Outlook for Next 6-9 Months
TURKU, Finland and BOSTON, Oct. 03, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Oy (AIM: FARN,…
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at CHEST 2023
PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support…